Menopause NOT linked to worsening disability in women with relapsing #MS, says a landmark study from Monash University in @JAMANeuro.
Ageing is the driver.
Findings offer reassurance/clarity to women heading into midlife with MS.
➡️ https://t.co/VJA1E1MxuA
@vjokubaitis
"We investigated the impact of #menopause on disability progression in women living with [#MultipleSclerosis] and found menopause did not accelerate time to #progression milestones, including CDP and SPMS." https://t.co/Qm2VZBdgCM @fm_bridge
🚨 Our study just been published in @JAMANeuro#Menopause is not a major driver of #MultipleSclerosis disability progression.
🔗 https://t.co/tCijSnWPRt
🧵 below 👇
📉 In the secondary analysis, there was no inflection point in EDSS worsening across the menopausal transition. Menopause did not accelerate disability accumulation.
Today we published an important piece of evidence showing that in women with relapsing #MultipleSclerosis, aging rather than #menopause, is the primary driver of disability in midlife, providing reassurance that menopause will not worsen MS physical disability. Read more below
Congratulations to @MasturaMonif from @STMneurosci@AlfredHealth for winning the prestigious Leonard Cox award from The Australian & NZ Association of Neurologists for outstanding research in their first 10 years post-FRACP. What a wonderful scientific and life journey!!
🚨 Mark your calendars for Monday, May 27th! 🗓️ Excited to host the @IntNatlWiMS Global Epidemiology meeting. 🌍🌎🌏 Our lineup includes two amazing speakers: @fm_bridge diving into risk of cervical cancer w/DMTs and Dr. Nourbakhsh into MS stigma. Don't miss out! @EthelScl